These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 33650314)

  • 1. Clinical pharmacology and dosing regimen optimization of neonatal opioid withdrawal syndrome treatments.
    Tang F; Ng CM; Bada HS; Leggas M
    Clin Transl Sci; 2021 Jul; 14(4):1231-1249. PubMed ID: 33650314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy of neonatal opioid withdrawal syndrome: a review of pharmacokinetics and pharmacodynamics.
    van Hoogdalem MW; McPhail BT; Hahn D; Wexelblatt SL; Akinbi HT; Vinks AA; Mizuno T
    Expert Opin Drug Metab Toxicol; 2021 Jan; 17(1):87-103. PubMed ID: 33049155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid Treatment for Neonatal Opioid Withdrawal Syndrome: Current Challenges and Future Approaches.
    McPhail BT; Emoto C; Butler D; Fukuda T; Akinbi H; Vinks AA
    J Clin Pharmacol; 2021 Jul; 61(7):857-870. PubMed ID: 33382111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiologically-Based Pharmacokinetic Modeling to Investigate the Effect of Maturation on Buprenorphine Pharmacokinetics in Newborns with Neonatal Opioid Withdrawal Syndrome.
    van Hoogdalem MW; Johnson TN; McPhail BT; Kamatkar S; Wexelblatt SL; Ward LP; Christians U; Akinbi HT; Vinks AA; Mizuno T
    Clin Pharmacol Ther; 2022 Feb; 111(2):496-508. PubMed ID: 34679189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacometric dose optimization of buprenorphine in neonatal opioid withdrawal syndrome.
    Eudy-Byrne R; Zane N; Adeniyi-Jones SC; Gastonguay MR; Ruiz-Garcia A; Kaushal G; Kraft WK
    Clin Transl Sci; 2021 Nov; 14(6):2171-2183. PubMed ID: 34080312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic approaches for neonatal abstinence syndrome: a systematic review of randomized clinical trials.
    Ghazanfarpour M; Najafi MN; Roozbeh N; Mashhadi ME; Keramat-Roudi A; Mégarbane B; Tsatsakis A; Moghaddam MMM; Rezaee R
    Daru; 2019 Jun; 27(1):423-431. PubMed ID: 31093953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal abstinence syndrome.
    Coyle MG; Brogly SB; Ahmed MS; Patrick SW; Jones HE
    Nat Rev Dis Primers; 2018 Nov; 4(1):47. PubMed ID: 30467370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine in Neonatal Abstinence Syndrome.
    Kraft WK
    Clin Pharmacol Ther; 2018 Jan; 103(1):112-119. PubMed ID: 29105752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenobarbital and Clonidine as Secondary Medications for Neonatal Opioid Withdrawal Syndrome.
    Merhar SL; Ounpraseuth S; Devlin LA; Poindexter BB; Young LW; Berkey SD; Crowley M; Czynski AJ; Kiefer AS; Whalen BL; Das A; Fuller JF; Higgins RD; Thombre V; Lester BM; Smith PB; Newman S; Sánchez PJ; Smith MC; Simon AE;
    Pediatrics; 2021 Mar; 147(3):. PubMed ID: 33632932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pragmatic, randomized, blinded trial to shorten pharmacologic treatment of newborns with neonatal opioid withdrawal syndrome (NOWS).
    Czynski A; Laptook A; Das A; Smith B; Simon A; Greenberg R; Annett R; Lee J; Snowden J; Pedroza C; Lester B; Eggleston B; Bremer D; McGowan E
    Trials; 2023 Jul; 24(1):466. PubMed ID: 37480087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy for Neonatal Abstinence Syndrome: Choosing the Right Opioid or No Opioid at All.
    McPherson C
    Neonatal Netw; 2016; 35(5):314-20. PubMed ID: 27636696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Factors Associated with the Occurrence of Neonatal Opioid Withdrawal Syndrome: A Review.
    Kelty E; Preen DB
    CNS Drugs; 2019 Nov; 33(11):1113-1120. PubMed ID: 31686408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness of opioid replacement agents for neonatal opioid withdrawal syndrome: a systematic review and meta-analysis.
    Lee JJ; Chen J; Eisler L; Li G; Davis JM; Sun LS
    J Perinatol; 2019 Nov; 39(11):1535-1545. PubMed ID: 31316147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal opioid withdrawal syndrome: a review of the science and a look toward the use of buprenorphine for affected infants.
    Devlin LA; Young LW; Kraft WK; Wachman EM; Czynski A; Merhar SL; Winhusen T; Jones HE; Poindexter BB; Wakschlag LS; Salisbury AL; Matthews AG; Davis JM
    J Perinatol; 2022 Mar; 42(3):300-306. PubMed ID: 34556799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal Opioid Withdrawal Syndrome: A Comparison of As-Needed Pharmacotherapy.
    Morrison TM; MacMillan KDL; Melvin P; Singh R; Murzycki J; Van Vleet MW; Rothstein R; O'Shea TF; Gupta M; Schiff DM; Wachman EM
    Hosp Pediatr; 2022 May; 12(5):530-538. PubMed ID: 35403199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the Care of Infants With Prenatal Opioid Exposure and Neonatal Opioid Withdrawal Syndrome.
    Mascarenhas M; Wachman EM; Chandra I; Xue R; Sarathy L; Schiff DM
    Pediatrics; 2024 Jan; 153(2):. PubMed ID: 38178779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal Opioid Withdrawal Syndrome (NOWS): A Transgenerational Echo of the Opioid Crisis.
    Weller AE; Crist RC; Reiner BC; Doyle GA; Berrettini WH
    Cold Spring Harb Perspect Med; 2021 Mar; 11(3):. PubMed ID: 32229609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abstinence scoring algorithms for treatment of neonatal opioid withdrawal syndrome (NOWS).
    Maisel BA; Adeniyi-Jones SC; Selvage E; Ng S; Kraft WK; Chervoneva I
    J Perinatol; 2024 Aug; 44(8):1132-1136. PubMed ID: 38366118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methadone dosing strategies in preterm neonates can be simplified.
    van Donge T; Samiee-Zafarghandy S; Pfister M; Koch G; Kalani M; Bordbar A; van den Anker J
    Br J Clin Pharmacol; 2019 Jun; 85(6):1348-1356. PubMed ID: 30805946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Care-by-parent model as a tool for reduction of neonatal opioid withdrawal syndrome in neonates exposed to buprenorphine maintenance therapy in-utero.
    Lawlor ML; Shook LA; McQuerry K; Srinivasan A; Johnson QB; Chavan NR; Critchfield AS
    J Matern Fetal Neonatal Med; 2020 Aug; 33(16):2718-2722. PubMed ID: 30563376
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.